
0:00
11:59
This episode: A probiotic strain of E. coli can target and destroy pathogens that survive a treatment of antibiotics!
Download Episode (8.2 MB, 12 minutes)
Show notes:
Microbe of the episode: Streptomyces griseoruber
In this study, a probiotic strain of Escherichia coli was used to target potentially pathogenic E. coli bacteria that can survive treatment with a particularly effective type of antibiotic, fluoroquinolones. This probiotic strain, called Nissle, delivers toxins directly to the survivors, preventing resistant pathogens from proliferating.
Journal Paper:
Hare PJ, Englander HE, Mok WWK. 2022. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. J Appl Microbiol 132:4020–4032.
Email questions or comments to bacteriofiles at gmail dot com. Thanks for listening!
Subscribe: Apple Podcasts, Google Podcasts, Android, or RSS. Support the show at Patreon, or check out the show at Twitter or Facebook.
Więcej odcinków z kanału "BacterioFiles"



Nie przegap odcinka z kanału “BacterioFiles”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








